Code of Maryland Regulations (Last Updated: April 6, 2021) |
Title 10. Maryland Department of Health |
Part 5. |
Subtitle 62. NATALIE LAPRADE MEDICAL CANNABIS COMMISSION |
Chapter 10.62.23. Medical Cannabis Concentrates and Medical Cannabis-Infused Products |
Sec. 10.62.23.03. Independent Testing Laboratory Selection and Responsibility
-
Upon successful completion of a validation process, the licensee shall use an independent testing laboratory:
A. That has adopted a standard operating procedure to test medical cannabis and medical cannabis concentrate that is approved by an accreditation body that is a signatory to the International Laboratory Accreditation Cooperation (ILAC) Mutual Recognition Arrangement;
B. To have an agent of the independent testing laboratory obtain samples according to a statistically valid sampling method for each lot;
C. To analyze the samples according to:
(1) The most current version of the cannabis Inflorescence monograph published by the American Herbal Pharmacopeia (AHP); or
(2) A scientifically valid methodology that is equal or superior to that of the AHP monograph;
D. In the event of a test result which falls out of specification, the laboratory shall follow their standard operating procedure to confirm or refute the original result;
E. To destroy the remains of the sample of medical cannabis after analysis is completed; and
F. To destroy the remains of the sample of medical cannabis after analysis is completed.